Cargando…
Prostate cancer : a multidisciplinary approach to diagnosis and management /
"With an emphasis on multidisciplinary collaboration and decision-making, this practical resource reflects the extraordinary advances in the treatment of prostate cancer during the past five years. Approximately thirty international, leading-edge investigators describe the most current evidence...
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | , , , |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
New York :
DemosMedical,
[2015]
|
| Colección: | Current multidisciplinary oncology.
|
| Temas: | |
| Acceso en línea: | Texto completo |
Tabla de Contenidos:
- Part I: Epidemiology, screening, and diagnosis
- Introduction: the multidisciplinary approach to prostate cancer
- Epidemiology of prostate cancer
- Diet and prostate cancer
- Epidemiology: obesity as a risk factor
- Screening and diagnosis: the pros of PSA screening
- The argument against prostate cancer screening
- How do we improve PSA accuracy?
- Screening and diagnosis: an update on the ISUP-modified Gleason score and its controversies
- Evaluation of distant disease: the utility of nuclear imaging
- Current approaches to prostate cancer staging and risk stratification: in the midst of a paradigm shift
- Novel molecular and genotype profiling in prostate cancer: the future of screening, diagnosis, and staging
- Genomics and risk assessment
- Future direction: novel urine and serum markers
- Morphometric and systems pathology: the future of screening, diagnosis, and staging
- PET: the future of screening, diagnosis, and staging for prostate cancer
- DCE MRI and MR spectroscopy: the future of screening, diagnosis, and staging
- Future direction: contrast ultrasound
- Counseling patients with clinically localized, high-risk prostate cancer
- Part II: Treatment for low-risk, localized disease
- Active surveillance for prostate cancer: an overview
- Treatment of low-risk, localized prostate cancer: a holistic approach with diet
- Traditional radical prostatectomy
- Laparoscopic radical prostatectomy: techniques and complications
- Robotic radical prostatectomy: the Thomas Jefferson University experience
- Surgical training, digital capture, virtual reality, and the future of radical prostatectomy
- External beam radiation therapy: conventional fractionation
- Hypofractionated radiation therapy for localized prostate cancer
- Stereotactic body radiation therapy for localized prostate cancer
- Treatment of low-risk, localized prostate cancer: use of proton therapy
- Treatment of low-risk, localized prostate cancer: brachytherapy
- Treatment of low-risk, localized prostate cancer: general principles of ablative and focal therapies
- Hyperthermia for prostate cancer
- Ablative techniques: vascular targeted photodynamic therapy
- Laser ablative techniques for prostate cancer
- Irreversible electroporation (IRE) prostate ablation
- Quality of life with surgery
- Quality of life with androgen deprivation therapy
- Quality of life with external beam radiation therapy
- Quality of life with brachytherapy for low-risk localized prostate cancer
- Role for comparative effectiveness research in treatment decision making
- Defining treatment failure for localized prostate cancer: PSA and beyond
- Prognosis after biochemical failure and surrogate endpoints for prostate cancer-specific mortality
- Part III: Treatment for high-risk, localized, and locally advanced disease
- treatment of high-risk prostate cancer: the role of low-dose rate (LDR) and high-dose rate (HDR) brachytherapy
- Part IV: Treatment of disseminated disease
- Salvage therapy for rising PSA
- Metastatic hormone sensitive prostate cancer
- Metastatic castrate-resistant prostate cancer: mechanisms of hormone escape
- Metastatic castrate-resistant prostate cancer: role of chemotherapy and multifaceted treatment paradigms
- Metastatic castrate-resistant prostate cancer: role of androgen signaling inhibitors
- Radiation and the immune system
- Immunotherapy: agents targeting prostate cancer
- Treatment of bony metastases: inhibitors of bone resorption
- Treatment of bone metastases: radiopharmaceuticals
- Prognostication of metastatic castration-resistant prostate cancer.